» Articles » PMID: 21431275

The 10-year COPD Programme in Finland: Effects on Quality of Diagnosis, Smoking, Prevalence, Hospital Admissions and Mortality

Overview
Date 2011 Mar 25
PMID 21431275
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Finnish National Programme for Chronic Bronchitis and Chronic Obstructive Pulmonary Disease (COPD) 1998-2007 was set up to reduce the prevalence of COPD, improve COPD diagnosis and care, reduce the number of moderate to severe cases of the disease, and reduce hospitalisations and treatment costs due to COPD. Over 900 events for 25,000 participating healthcare workers were arranged. The major strengths of this programme included multidisciplinary strategies and web-based guidelines in nearly all primary health care centres around the country.

Methods: Data from national registries, epidemiological studies and questionnaires were used to measure whether the goals had been reached.

Results: The prevalence of COPD remained unchanged. Smoking decreased in males from 30% to 26% (p<0.001) and in females from 20% to 17% (p<0.001). Significant improvements in the quality of spirometry were obtained. Hospitalisation decreased by 39.7% (p<0.001). COPD costs were 88% lower than had been anticipated from earlier investigations. No increase in COPD mortality was observed.

Conclusions: In combination with other efforts, the Finnish 10-year COPD Programme had significant positive consequences: no further increases in COPD prevalence, reduced smoking prevalence, improved quality of diagnosis, and reduction in COPD-related hospitalisations.

Citing Articles

Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland.

Juntunen P, Salmela P, Pakkasela J, Karjalainen J, Lehtimaki L BMC Pulm Med. 2024; 24(1):64.

PMID: 38297257 PMC: 10829254. DOI: 10.1186/s12890-024-02870-9.


Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019.

Stone P, Osen M, Ellis A, Coaker R, Quint J Int J Chron Obstruct Pulmon Dis. 2023; 18:1565-1574.

PMID: 37497381 PMC: 10368107. DOI: 10.2147/COPD.S411739.


Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts.

Athlin A, Lisspers K, Hasselgren M, Stallberg B, Janson C, Montgomery S NPJ Prim Care Respir Med. 2023; 33(1):23.

PMID: 37264017 PMC: 10235108. DOI: 10.1038/s41533-023-00345-8.


Five-Year Trends in Direct Costs of Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-3.

Ozdemir T, Kilic H, Demirci N, Ozdilekcan C, Bektemur G, Turkkani M Turk Thorac J. 2022; 22(5):393-398.

PMID: 35110213 PMC: 8975325. DOI: 10.5152/TurkThoracJ.2021.19150.


The current status of chronic obstructive pulmonary disease awareness, treatments, and plans for improvement in South Korea: a narrative review.

Park Y, Yoo K J Thorac Dis. 2021; 13(6):3898-3906.

PMID: 34277079 PMC: 8264709. DOI: 10.21037/jtd-21-172.